Vitamin D3 Shows Promise in Reducing Cancer Deaths, Studies Reveal

Vitamin D3 is often linked to bone health, but recent studies suggest it may also play a role in cancer prevention. Over the past five years, researchers have examined its effects, with mixed findings on whether it reduces cancer cases. However, evidence points to a possible drop in cancer deaths for those taking supplements regularly. Between 2021 and 2026, multiple studies explored how vitamin D3 might influence cancer risk. A meta-analysis by Kuznia and colleagues reviewed 14 randomised controlled trials and found no clear drop in cancer cases. Yet it did show a steady 12–13% reduction in cancer deaths among people taking daily supplements.

The US National Institutes of Health (NIH) also analysed data and discovered that every 20 nmol/L increase in blood levels of 25(OH)D was linked to a 7% lower cancer risk and a 2% lower chance of dying from it. Meanwhile, the German Cancer Research Centre (DKFZ) estimated that up to 30,000 cancer deaths could be prevented each year in Germans over 50 if they took vitamin D3 supplements. However, the large-scale VITAL study found no effect on cancer rates, likely due to differences in how individuals respond. Vitamin D remains one of the most widely used supplements, especially in winter when the body produces less of it naturally. Molecular biologist Hanna Heikenwälder, based at the University of Tübingen, has written extensively on cancer prevention in her book *Cancer: The End of Fear*.

The research so far does not prove that vitamin D3 stops cancer from developing. But the data does suggest a possible benefit in lowering cancer death rates, particularly with regular supplementation. Further studies may clarify how best to use it for long-term health.